Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS Wales Shared Services Partnership
2 Capital Quarter, Tyndall Street
Cardiff
CF10 4BZ
UK
Contact person: Nadine Stokes
Telephone: +44 2920902253
E-mail: nadine.stokes@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
OraSure, OraQuick Hepatitis C antibody, Point of Care test
II.1.2) Main CPV code
38912000
II.1.3) Type of contract
Supplies
II.1.4) Short description
OraSure, OraQuick Hepatitis C antibody, Point of Care test
II.1.6) Information about lots
This contract is divided into lots:
No
II.2) Description
II.2.3) Place of performance
NUTS code:
UKL
Main site or place of performance:
All Wales
II.2.4) Description of the procurement
OraQuick HCV test detects antibodies against hepatitis C virus and can be used on oral fluid, finger stick blood, venous blood, plasma or serum, giving results in 20–40 minutes. Eleven published studies showed that the OraQuick HCV has very high sensitivity and specificity
II.2.5) Award criteria
Quality criterion: As per procurement documents
/ Weighting: 100
Price
/ Weighting:
0
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
The OraQuick HCV test detects antibodies against hepatitis C virus and can be used on oral fluid, finger stick blood, venous blood, plasma or serum, giving results in 20–40 minutes. Eleven published studies showed that the OraQuick HCV has very high sensitivity and specificity.
There are no alternative suppliers who have the CE marked technology for the OraQuick HCV rapid antibody test.
As such, there are no identified alternative suppliers who can complete all of the following elements as one test:
- The OraQuick HCV rapid antibody test plus absorbent packet
- An OraQuick HCV developer solution (0.75ml phosphate buffered saline solution containing polymers and a antimicrobial agent)
- Reusable test stands
- Collection loops
- Package insert
- Rapid HCV results ready in 20-40 minutes
- The OraQuick HCV test comes with quality control reagents include:
- When each new operator is using the kit
- Whenever a new test it lot is opened
- Whenever the kit storage area falls outside of 2C-30C
- Whenever the kit testing area fall outside of 15C-37C
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2023/S 000-007677
Section V: Award of contract
Contract No: N/a
A contract/lot is awarded:
No
V.1 Information on non-award
The contract/lot is not awarded
Other reasons (discontinuation of procedure)
Section VI: Complementary information
VI.3) Additional information
1. The Contracting Authority reserves the right to award the contract in whole, in part or annul the tendering process and not award any contract.
(WA Ref:130046)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
NHS Wales Shared Services Partnership on behalf of Public Health Wales NHS Trust will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.
Unsuccessful tenderers and applicants are entitled to receive reasons for the decision, including the characteristics and relative advantages of the winning bid and the reasons why the tenderer/applicant was unsuccessful.
Should additional information be required it should be requested of the addressee in section I.1.
Aggrieved parties who have been harmed or are at risk of harm by breach of the procurement rules have the right to take action in the High Court (England and Wales). Any such action is subject to strict time limits in accordance with the Public Contracts (Amendments) Regulations 2015
VI.5) Date of dispatch of this notice
16/03/2023